LENSAR, Inc. (LNSR) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Devices industria. La empresa tiene su sede en Orlando, FL, United States. El CEO actual es Nicholas T. Curtis.
LNSR tiene fecha de IPO 2020-10-02, 140 empleados a tiempo completo, cotiza en el NASDAQ Capital Marke, una capitalización de mercado de $75.6M.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
